<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kozminsky M</submitter><funding>University of California, Berkeley</funding><funding>Fred Hutchinson Cancer Research Center</funding><funding>NIH/NCI</funding><funding>CITRIS COVID 19 Response Seed Funding</funding><funding>University of California Berkeley</funding><funding>NCI NIH HHS</funding><funding>Michael and Margaret Checca</funding><funding>University of California Cancer Research Coordinating Committee Fellowship</funding><pagination>e2101166</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8646752</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(23)</volume><pubmed_abstract>Lipid-based nanoparticles have been applied extensively in drug delivery and vaccine strategies and are finding diverse applications in the coronavirus disease 2019 (COVID-19) pandemic-from vaccine-component encapsulation to modeling the virus, itself. High-throughput, highly flexible methods for characterization are of great benefit to the development of liposomes featuring surface proteins. DNA-directed patterning is one such method that offers versatility in immobilizing and segregating lipid-based nanoparticles for subsequent analysis. Here, oligonucleotides are selectively conjugated onto a glass substrate and then hybridized to complementary oligonucleotides tagged to liposomes, patterning them with great control and precision. The power of DNA-directed patterning is demonstrated by </pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>DNA-Directed Patterning for Versatile Validation and Characterization of a Lipid-Based Nanoparticle Model of SARS-CoV-2.</pubmed_title><pmcid>PMC8646752</pmcid><funding_grant_id>F32 CA243354</funding_grant_id><funding_grant_id>1F32CA243354-01</funding_grant_id><pubmed_authors>Sohn LL</pubmed_authors><pubmed_authors>Carey TR</pubmed_authors><pubmed_authors>Kozminsky M</pubmed_authors></additional><is_claimable>false</is_claimable><name>DNA-Directed Patterning for Versatile Validation and Characterization of a Lipid-Based Nanoparticle Model of SARS-CoV-2.</name><description>Lipid-based nanoparticles have been applied extensively in drug delivery and vaccine strategies and are finding diverse applications in the coronavirus disease 2019 (COVID-19) pandemic-from vaccine-component encapsulation to modeling the virus, itself. High-throughput, highly flexible methods for characterization are of great benefit to the development of liposomes featuring surface proteins. DNA-directed patterning is one such method that offers versatility in immobilizing and segregating lipid-based nanoparticles for subsequent analysis. Here, oligonucleotides are selectively conjugated onto a glass substrate and then hybridized to complementary oligonucleotides tagged to liposomes, patterning them with great control and precision. The power of DNA-directed patterning is demonstrated by </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-08T00:05:41.157Z</modification><creation>2022-02-11T14:17:26.638Z</creation></dates><accession>S-EPMC8646752</accession><cross_references><pubmed>34672117</pubmed><doi>10.1002/advs.202101166</doi></cross_references></HashMap>